Blarcamesine Completed Phase 3 Trials for Rett Syndrome Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03941444ANAVEX2-73 Study in Patients With Rett Syndrome